Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2011. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of director share transactions rather than a financial performance report.
Material Changes
The filing details specific share transactions on June 30, 2011, involving Mr. A P Witty:
- Receipt of 45,000 Ordinary shares via gift from his wife, Mrs. C Witty.
- Disposal of 1,500 Ordinary shares via gift.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the aforementioned share transfers in accordance with Disclosure Rule 3.1.4R(1)(a) and (c).
Key Facts for Investors
- Director Mr. A P Witty received a net increase of 43,500 shares through gift transactions on June 30, 2011.
- The Company was advised of these transactions on June 30, 2011, and the report was signed on July 1, 2011.
- No financial performance data or strategic outlook is included in this specific filing.